Targeted integration of EpCAM-specific CAR in human induced pluripotent stem cells and their differentiation into NK cells
Abstract Background Redirection of natural killer (NK) cells with chimeric antigen receptors (CAR) is attractive in developing off-the-shelf CAR therapeutics for cancer treatment. However, the site-specific integration of a CAR gene into NK cells remains challenging. Methods In the present study, we...
Main Authors: | Shin Yi Tang, Shijun Zha, Zhicheng Du, Jieming Zeng, Detu Zhu, Yumei Luo, Shu Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-11-01
|
Series: | Stem Cell Research & Therapy |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13287-021-02648-4 |
Similar Items
-
Optimization of AAV6 transduction enhances site-specific genome editing of primary human lymphocytes
by: Geoffrey L. Rogers, et al.
Published: (2021-12-01) -
EpCAM-targeting CAR-T cells against hepatoma cells in vitro
by: WANG Song, et al.
Published: (2023-09-01) -
Immune cells and RBCs derived from human induced pluripotent stem cells: method, progress, prospective challenges
by: Jin-he Jiang, et al.
Published: (2024-01-01) -
EpCAM as Modulator of Tissue Plasticity
by: François Fagotto
Published: (2020-09-01) -
Targeted, homology-driven gene insertion in stem cells by ZFN-loaded ‘all-in-one’ lentiviral vectors
by: Yujia Cai, et al.
Published: (2016-06-01)